{"id":"https://openalex.org/W2591473971","doi":"https://doi.org/10.1200/jop.2014.001685","title":"Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2\u2013Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary","display_name":"Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2\u2013Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2591473971","doi":"https://doi.org/10.1200/jop.2014.001685","mag":"2591473971"},"language":"en","primary_location":{"id":"doi:10.1200/jop.2014.001685","doi":"https://doi.org/10.1200/jop.2014.001685","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2014.001685","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Ann H. Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867","https://openalex.org/I4210117453","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103543463","display_name":"Ian E. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Ian E. Smith","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867","https://openalex.org/I4210117453","https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072782837","display_name":"R. Bryan Rumble","orcid":"https://orcid.org/0000-0002-2786-2925","observed_orcids":["https://orcid.org/0000-0002-2786-2925"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"R. Bryan Rumble","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Royal Marsden Hospital, London, United Kingdom; and American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867","https://openalex.org/I4210117453","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5508,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.63566529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"11","issue":"1","first_page":"42","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.13210000097751617,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.03269999846816063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9100000262260437},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.878000020980835},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.914405345916748},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.7799164652824402},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.7402307987213135},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.7218360900878906},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6477444171905518},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6079948544502258},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.5638266801834106},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5613906979560852},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5236893892288208},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5118440985679626},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.490922749042511},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3359505534172058},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2636856734752655},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2035355567932129}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jop.2014.001685","doi":"https://doi.org/10.1200/jop.2014.001685","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2014.001685","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W2116144791","https://openalex.org/W2163750567","https://openalex.org/W2169961966","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2833120298","https://openalex.org/W2591456506","https://openalex.org/W2584266517","https://openalex.org/W2904991649","https://openalex.org/W2346570573","https://openalex.org/W2809354950","https://openalex.org/W4289784923","https://openalex.org/W2116144791","https://openalex.org/W4225665873","https://openalex.org/W7099906934"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2017-03-03T00:00:00"}